Antidepressants and weight changes
Pro Research Analysisby 
Searched over 200M research papers
Antidepressants and Weight Changes: Overview and Key Findings
Antidepressant medications are widely used to treat depression, but many are associated with changes in body weight, which can be a significant concern for patients and clinicians alike 1348. The risk and degree of weight change can vary greatly depending on the specific antidepressant, the duration of treatment, and individual patient factors 1346.
Weight Gain Associated with Specific Antidepressants
Tricyclic Antidepressants (TCAs) and Mirtazapine
Tricyclic antidepressants (such as amitriptyline, nortriptyline, and desipramine) are consistently linked to significant weight gain, with amitriptyline showing the greatest increase among TCAs 35810. Mirtazapine, although not a TCA, also leads to notable weight gain and is often placed between SSRIs and TCAs in terms of risk 1389.
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs show variable effects on weight. Paroxetine is more likely to cause weight gain, especially with long-term use, while citalopram, escitalopram, and sertraline are also associated with increased weight, though to a lesser extent 2368+2 MORE. Fluoxetine, on the other hand, may cause weight loss in the short term, but this effect is often limited to the acute phase of treatment 349.
Other Antidepressants
Bupropion stands out as an antidepressant associated with weight loss or the least weight gain among commonly prescribed agents 1234+3 MORE. Newer agents like gepirone may also have weight-neutral or weight-reducing effects, but more research is needed .
Long-Term and Population-Level Effects
Long-term use of antidepressants, especially TCAs and SSRIs, is linked to a steeper increase in body mass index (BMI), waist circumference, and fat mass, suggesting that sustained treatment can have unfavorable effects on weight and metabolic health 610. These effects are independent of the depressive episodes themselves and are more pronounced with continued use .
Mechanisms Behind Antidepressant-Induced Weight Changes
Weight gain from antidepressants is thought to be related to off-target effects on histamine and serotonin pathways that promote appetite . Some antidepressants may also reduce resting metabolic rate, increasing energy efficiency and leading to weight gain even without increased caloric intake . However, not all antidepressants have these effects, and some, like fluvoxamine, may actually increase metabolic rate and promote weight loss .
Clinical Implications and Management Strategies
Weight gain is a common side effect of both acute and long-term antidepressant treatment and can contribute to medication noncompliance . For patients at risk of obesity or metabolic complications, clinicians are encouraged to consider antidepressants with lower risk of weight gain, such as bupropion or fluoxetine, and to monitor weight regularly 1234+3 MORE. Switching to weight-neutral alternatives, integrating behavioral interventions, or using adjunctive anti-obesity medications may help manage or prevent weight gain in susceptible individuals .
Conclusion
Antidepressants differ in their effects on body weight, with some agents like TCAs, mirtazapine, and certain SSRIs more likely to cause weight gain, while others like bupropion and fluoxetine are associated with less risk or even weight loss. Long-term use increases the risk of weight gain, making it important for clinicians to tailor antidepressant choices to individual patient needs and metabolic risk profiles. Regular monitoring and proactive management can help minimize the impact of antidepressant-induced weight changes.
Sources and full results
Most relevant research papers on this topic